(Q43042597)

12 November 2017

title

Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina (English)

1 reference

12 November 2017

1 reference

1 reference

T Stewart

1

1 reference

12 November 2017

N Pavlakis

series ordinal

2

1 reference

12 November 2017

M Ward

series ordinal

3

1 reference

12 November 2017

publication date

1 April 2010

1 reference

Internal Medicine Journal

12 November 2017

published in

1 reference

12 November 2017

volume

40

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

303-307

1 reference

Coronary artery spasm induced by 5-fluorouracil

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02144.X

Prinzmetal's angina during 5-fluorouracil chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02144.X

Fluorouracil cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02144.X

Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02144.X

Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02144.X

The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02144.X

Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02144.X

Cardiotoxicity of the antiproliferative compound fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02144.X

Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02144.X

Cardiac toxicity associated with capecitabine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02144.X

Raltitrexed: current clinical status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2009.02144.X

10.1111/J.1445-5994.2009.02144.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference